Adagene Stock Performance
| ADAG Stock | USD 2.34 0.03 1.30% |
The firm shows a Beta (market volatility) of 0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Adagene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Adagene is expected to be smaller as well. At this point, Adagene has a negative expected return of -0.2%. Please make sure to confirm Adagene's total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if Adagene performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return 1.08 | Five Day Return 8.6 | Year To Date Return 19.13 | Ten Year Return (92.21) | All Time Return (92.21) |
1 | Are Medical Stocks Lagging Adagene This Year | 09/11/2024 |
2 | HC Wainwright Analysts Lift Earnings Estimates for Adagene Inc. - MarketBeat | 09/20/2024 |
3 | Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody ADG126 at Society for Immunotherapy of Cancer th Annual Meeting | 10/09/2024 |
4 | ADAG Shares Plummet amid Unfavorable Earnings Report | 10/22/2024 |
5 | Adagene shares downgraded to hold, target cut to 3.50 | 11/15/2024 |
6 | ADAG Stock Surges Amidst Biotech Sector Growth | 11/27/2024 |
| Begin Period Cash Flow | 143.8 M |
Adagene |
Adagene Relative Risk vs. Return Landscape
If you would invest 301.00 in Adagene on September 2, 2024 and sell it today you would lose (67.00) from holding Adagene or give up 22.26% of portfolio value over 90 days. Adagene is currently does not generate positive expected returns and assumes 6.1492% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Adagene, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Adagene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adagene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Adagene, and traders can use it to determine the average amount a Adagene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0325
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADAG |
Estimated Market Risk
| 6.15 actual daily | 54 54% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Adagene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adagene by adding Adagene to a well-diversified portfolio.
Adagene Fundamentals Growth
Adagene Stock prices reflect investors' perceptions of the future prospects and financial health of Adagene, and Adagene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adagene Stock performance.
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (45.35) % | ||||
| Current Valuation | 28.49 M | ||||
| Shares Outstanding | 44.27 M | ||||
| Price To Book | 1.83 X | ||||
| Price To Sales | 126.72 X | ||||
| Revenue | 18.11 M | ||||
| Gross Profit | 10.18 M | ||||
| EBITDA | (14.95 M) | ||||
| Net Income | (18.95 M) | ||||
| Cash And Equivalents | 168.04 M | ||||
| Cash Per Share | 3.87 X | ||||
| Total Debt | 22.31 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 3.10 X | ||||
| Book Value Per Share | 1.28 X | ||||
| Cash Flow From Operations | (28.45 M) | ||||
| Earnings Per Share | (0.72) X | ||||
| Market Capitalization | 108.46 M | ||||
| Total Asset | 115.73 M | ||||
| Retained Earnings | (277.75 M) | ||||
| Working Capital | 81.99 M | ||||
About Adagene Performance
By analyzing Adagene's fundamental ratios, stakeholders can gain valuable insights into Adagene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Adagene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Adagene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Capital Employed | (0.28) | (0.30) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.27) | (0.28) |
Things to note about Adagene performance evaluation
Checking the ongoing alerts about Adagene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adagene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Adagene generated a negative expected return over the last 90 days | |
| Adagene has high historical volatility and very poor performance | |
| Adagene has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.11 M. Net Loss for the year was (18.95 M) with profit before overhead, payroll, taxes, and interest of 10.18 M. | |
| Adagene currently holds about 168.04 M in cash with (28.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Adagene has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: ADAG Stock Surges Amidst Biotech Sector Growth |
- Analyzing Adagene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adagene's stock is overvalued or undervalued compared to its peers.
- Examining Adagene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Adagene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adagene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Adagene's stock. These opinions can provide insight into Adagene's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance |